Pharma Flashcards
mainstay of acs management
aspirin, oxygen, morphine
ecg!!
molecules to watch in nstemi/ua
nitroglycerin, heparin, oral beta blockers, clopidogrel, glycoprotein IIb/IIIa inhibitor
functions of molecules in nstemi
- improve blood flow
- dissolve clots
- reduce burden of heart
drugs/molecules involved in acs management
- oxygen
- acetylsalicylic acid
- nitroglycerin/nitrates
- morphine
- fibrinolytic therapy
- heparin
- beta blockers
t/f as long as the patient is breathing, has a heart rate, do an ecg
true
molecules involved in the management of vt
adenosine and beta blockers, amiodarone
indication for adenosine
supraventricular tachycardia (stable)
actions of adenosine
- stimulates adenosine receptors in heart and sm
- blocks conduction node through av node
- decreases sinus node automaticity
special considerations for adenosine
- record rhythm strip during administration
- administer via central venous access
- theophylline (adenosine receptor antagonist) reduced adenosine effectiveness
indication for amiodarone
- supraventricular tachycardia
- pulseless arrest (vf or pulseless vt)
t/f amiodarone can be used in pts with polymorphic vt (torsades)
false, it’s associated with prolonged qt interval which is made worse with antiarrhythmic drugs
t/f amiodarone should ONLY be used after defib/cardioversion and after first line drugs (epi or vasopressin) have failed to convert vt/vf
true
actions of amiodarone
- prolongs action potential duration and effective refractory period
- slows sinus rate
- prolongs pr and qt intervals
- noncompet inhib of a-adrenergic and b-adrenergic receptors
contraindications for amiodarone
sinus node dysfunction and 2nd degree and 3rd degree av block
precautions for amiodarone
- procainamide
- hepatic failure
- inc toxicity for other drugs
- long half life and drug interactions
primary management for adult bradycardia with pulse
atropine (atropa belladonna)
indication for atropine
- symptomatic bradycardia
- toxins/overdose (organophosphate, carbamate)
actions of atropine
- anticholinergic (sns stimulant)
- blocks acetylcholine and other muscarinic agonists at pns sites
- increases hr and co (blocks vagal stimulation)
- reduces saliva production, mydriasis
special considerations for atropine
- blocks bradycardic response to hypoxia = MONITOR WITH PULSE OXIMETER
- use in child with bradycardia during et intubation
- document when used in pts with head injury (due to dilation)
contraindications for atropine
- angle closure glaucoma
- tachyarrhythmias
- thyrotoxicosis
indication for dopamine
cardiogenic shock and distributive shock
actions of dopamine
- catecholamine, vasopressor, inotrope
- stimulates a-adrenergic receptors (inc svr)
- stimulates b1-adrenergic receptors
- sa node = inc hr
- ventricular effect = inc myocardial contractility, automaticity, conduction velocity
- stimulates b2-adrenergic receptors (inc hr, dec svr)
- stimulates dopaminergic receptors (renal, splanchnic dilation)
special considerations for dopamine
- do not mix with nahco3 (inactivates)
- inhibits tsh
- dose dependent effects (low dose = dopaminergic and b-adrenergic, high dose = a-adrenergic)
indications for epinephrine
- anaphylaxis
- bradycardia
- croup
- pulseless arrest
- shock / hypotension
- toxins/overdose